secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001438133-23-000032
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 2.0, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rebecca Robertson to succeed Kim Blickenstaff as Chair of Tandem Diabetes Board effective March 1, 2023
--------------------------------------------------------------------------------

- Kim Blickenstaff steps down as Chair but remains a board member; served as Chair since March 2020.
- Rebecca Robertson, board member since 2019 and General Partner at Versant Ventures, appointed Chair.
- No separate Lead Independent Director designated because Robertson is an independent director.
- 2022 cash bonuses for named executives paid at 50.8% of target; CEO Sheridan received $359,418.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000032/0001438133-23-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000032/tndm-20230217.htm
  HTML page:      https://secwatch.observer/filing/0001438133-23-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer